Studies have shown that high VEGF-C with high M2 ratio (CD163+/CD68+) was an independent prognostic factor in NSCLC patients and significantly associated with angiogenesis and lymphangiogenesis [127]. The gene discussed is VEGFC; the disease is non-small cell lung carcinoma.